# A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants

> **NCT07032597** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **AbbVie** · enrollment: 252 (actual)

## Conditions studied

- Mid Face Volume Deficit

## Interventions

- **DEVICE:** HArmonyCa Lidocaine Injectable Gel
- **DEVICE:** Restylane® Perlane® Lidocaine

## Key facts

- **NCT ID:** NCT07032597
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-26
- **Primary completion:** 2026-08
- **Final completion:** 2026-10
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07032597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07032597, "A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07032597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*